SBI Funds Management IPO Review: Business Model, Financials, GMP, Valuations, Risks & Key Facts
SBI Funds Management IPO: RHP-based review of price band, GMP, financials & risks, and why more than half its AUM is PMS, not mutual funds.
Read Full
NSE IPO 2026: DRHP Filed - Valuation, Risks and What Investors Should Know
NSE filed its DRHP on June 17, 2026. Expected IPO size ₹30,000 crore, 100% OFS, valuation ~₹5-6 lakh crore. At 58-68x P/E on declining FY26 earnings, here is what the prospectus does not emphasise - i
Read Full
Tata Sons Listing: Why the Case Is Getting Harder to Ignore
Tata Sons missed its RBI listing deadline. Deregistration stalled. Two Tata Trusts vice-chairmen now back listing. Full breakdown: shareholding, SP Group debt trap, and the case for going public.
Read Full
FY26 IPO Review: Record Collections, Poor Returns for Most Investors
FY26 saw 108 mainboard IPOs raise ₹1,75,186 crore - a record. Yet 71 of those IPOs are below their issue price. Here is the full performance breakdown, subscription data, and what it means for investo
Read Full
Omnitech Engineering IPO Review 2026: Business Model, Financials, GMP, Valuations, Risks & Key Facts
Omnitech Engineering IPO review 2026: issue size, price band, lot size, order book, business model, financials, valuation (EPS/P-E), use of proceeds for new facilities, key risks, and who it may suit.
Read Full
PNGS Reva Diamond Jewellery IPO Review 2026: Business Model, Financials, GMP, Valuations, Risks & Key Facts
PNGS Reva Diamond Jewellery IPO review 2026: price band, lot size, business model (FOCO/FOFO/COCO), financials, valuation, use of proceeds for 15 new stores, key risks, and who it may suit. Educationa
Read Full
Gaudium IVF IPO Review 2026: Business Model, Financials, GMP, Valuations, Risks & Key Facts
Gaudium IVF IPO review covering business model, financials, valuation, GMP, use of proceeds, risks, and who this Gaudium IVF stock may suit. A neutral, data-backed analysis for retail investors.
Read Full
Fractal Analytics IPO Review 2026: Business Model, Financials, GMP, Valuations, Risks & Key Facts
Fractal Analytics IPO review covering business model, financials, valuation, GMP, use of proceeds, risks, and who this AI-led company may suit. A neutral, data-backed analysis for retail investors.
Read Full
Shadowfax IPO Review 2026: Business Model, Financials, GMP, Valuations, Risks & Key Facts
Shadowfax IPO review covering business model, financials, valuation, GMP, peer comparison with Blue Dart and Delhivery, key risks, and who this logistics IPO may suit.
Read Full
Amagi Media Labs IPO Review 2026: Business Model, Timeline, GMP, Financials, Risks & Key Facts
Detailed Amagi Media Labs IPO review covering business model, financials, GMP, risks, use of proceeds, and who this ad-tech IPO may suit.
Read Full
BCCL IPO Review 2026: Business Model, Financials, Valuations, Risks & Key Facts
BCCL IPO review with price band, GMP snapshot, financials, key ratios, risks, timeline, and what drives earnings in a cyclical PSU coking coal business.
Read Full
IPO Funds Are Rising - But Why Isn’t Private Capex Picking Up?
India has raised record IPO funds, yet private sector capex remains weak. A closer look at how IPO money is actually used explains the gap.
Read Full